Larimar Therapeutics (LRMR) EPS (Diluted) Growth (1y) (2021 - 2025)
Larimar Therapeutics (LRMR) EPS (Diluted) Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 36.94% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 17,091.12% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 61.58% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -7.16% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 96.09% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Larimar Therapeutics | 37.00 Mn | -99.85 Mn | - | 74.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 74.92% |
| Sep 30, 2025 | -60.89% |
| Jun 30, 2025 | 16.05% |
| Mar 31, 2025 | -12.41% |
| Dec 31, 2024 | 6.09% |
| Sep 30, 2024 | -0.35% |
| Jun 30, 2024 | -42.39% |
| Mar 31, 2024 | -134.44% |
| Dec 31, 2023 | 35.23% |
| Sep 30, 2023 | 17.95% |
| Jun 30, 2023 | 37.89% |
| Mar 31, 2023 | 76.71% |
| Dec 31, 2022 | 29.28% |
| Sep 30, 2022 | 54.64% |
| Jun 30, 2022 | 55.55% |
| Mar 31, 2022 | 30.39% |
| Dec 31, 2021 | 28.96% |
| Sep 30, 2021 | -10.09% |
| Jun 30, 2021 | -2.56% |